Showing results (201-210 of 439) with videos related to

Sort By:
Pageof 44
Transboundary and Emerging Diseases|July 6, 2012
Epidemic threats to the European Union: expert views on six virus groupsL Kelly, A Brouwer, A Wilson, et al.
The European Respiratory Journal|December 30, 2017
Chest physician-reported, work-related, long-latency respiratory disease in Great BritainMelanie Carder, Andrew Darnton, Matthew Gittins, et al.
Journal of Cardiovascular Electrophysiology|April 15, 2015
A Novel Microwave Catheter Can Perform Noncontact Circumferential Endocardial Ablation in a Model of Pulmonary Vein IsolationPierre Qian, Michael Anthony Barry, Trang Nguyen, et al.
BMJ Open Sport & Exercise Medicine|December 1, 2016
Susceptibility to exertional heat illness and hospitalisation risk in UK military personnelMichael J Stacey, Iain T Parsons, David R Woods, et al.
The Journal of Biological Chemistry|January 17, 2003
Interaction of human NAD(P)H:quinone oxidoreductase 1 (NQO1) with the tumor suppressor protein p53 in cells and cell-free systemsAdil Anwar, Donna Dehn, David Siegel, et al.
Biochemistry|July 2, 2011
Indolequinone inhibitors of NRH:quinone oxidoreductase 2. Characterization of the mechanism of inhibition in both cell-free and cellular systemsChao Yan, Marine Dufour, David Siegel, et al.
Gastroenterology|August 10, 2015
Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013Lauren A Beste, Steven L Leipertz, Pamela K Green, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 2, 2015
Lung transplantation and concomitant cardiac surgery: Is it justified?Reshma Biniwale, David Ross, Amit Iyengar, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 10, 2003
EGF and TGF-alpha expression influence the developmental toxicity of TCDD: dose response and AhR phenotype in EGF, TGF-alpha, and EGF + TGF-alpha knockout miceBarbara D Abbott, Angela R Buckalew, Michael J DeVito, et al.
Molecular Cancer Therapeutics|August 8, 2006
5-Methoxy-1,2-dimethyl-3-[(4-nitrophenoxy)methyl]indole-4,7-dione, a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1, exhibits activity against human pancreatic cancer in vitro and in vivoDonna L Dehn, David Siegel, Khan Shoeb Zafar, et al.
Pageof 44